212 related articles for article (PubMed ID: 8953566)
1. Coenzyme Q, peroxidation and cytochrome oxidase features after parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria from Macaca fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine.
Battino M; Littarru GP; Gorini A; Villa RF
Neurochem Res; 1996 Dec; 21(12):1505-14. PubMed ID: 8953566
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial factors involved in Parkinson's disease by MPTP toxicity in Macaca fascicularis and drug effect.
Villa RF; Arnaboldi R; Ghigini B; Gorini A
Neurochem Res; 1992 Nov; 17(11):1147-54. PubMed ID: 1461362
[TBL] [Abstract][Full Text] [Related]
3. Parkinson-like disease by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in Macaca fascicularis: synaptosomal metabolism and action of dihydroergocriptine.
Villa RF; Arnaboldi R; Ghigini B; Gorini A
Neurochem Res; 1994 Mar; 19(3):229-36. PubMed ID: 8177363
[TBL] [Abstract][Full Text] [Related]
4. Experimental Parkinson's disease in monkeys. Effect of ergot alkaloid derivative on lipid peroxidation in different brain areas.
Marzatico F; Café C; Taborelli M; Benzi G
Neurochem Res; 1993 Oct; 18(10):1101-6. PubMed ID: 8255359
[TBL] [Abstract][Full Text] [Related]
5. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
Ebadi M; Govitrapong P; Sharma S; Muralikrishnan D; Shavali S; Pellett L; Schafer R; Albano C; Eken J
Biol Signals Recept; 2001; 10(3-4):224-53. PubMed ID: 11351130
[TBL] [Abstract][Full Text] [Related]
6. A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease.
Shults CW; Haas RH; Beal MF
Biofactors; 1999; 9(2-4):267-72. PubMed ID: 10416040
[TBL] [Abstract][Full Text] [Related]
7. Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease.
Schwartzman RJ; Alexander GM
Brain Res; 1985 Dec; 358(1-2):137-43. PubMed ID: 3878182
[TBL] [Abstract][Full Text] [Related]
8. Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)].
Degryse AD; Colpaert FC
Brain Res Bull; 1986 May; 16(5):561-71. PubMed ID: 3488798
[TBL] [Abstract][Full Text] [Related]
9. Effect of ageing and ischemia on enzymatic activities linked to Krebs' cycle, electron transfer chain, glutamate and aminoacids metabolism of free and intrasynaptic mitochondria of cerebral cortex.
Villa RF; Gorini A; Hoyer S
Neurochem Res; 2009 Dec; 34(12):2102-16. PubMed ID: 19495970
[TBL] [Abstract][Full Text] [Related]
10. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.
Pifl C; Schingnitz G; Hornykiewicz O
Neuroscience; 1991; 44(3):591-605. PubMed ID: 1754053
[TBL] [Abstract][Full Text] [Related]
11. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.
Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H
Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546
[TBL] [Abstract][Full Text] [Related]
12. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
German DC; Dubach M; Askari S; Speciale SG; Bowden DM
Neuroscience; 1988 Jan; 24(1):161-74. PubMed ID: 3259295
[TBL] [Abstract][Full Text] [Related]
13. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
14. Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates.
Ghilardi MF; Chung E; Bodis-Wollner I; Dvorzniak M; Glover A; Onofrj M
Life Sci; 1988; 43(3):255-62. PubMed ID: 3260986
[TBL] [Abstract][Full Text] [Related]
15. Biochemical evaluations in skeletal muscles of primates with MPTP Parkinson-like syndrome.
Pastoris O; Dossena M; Foppa P; Catapano M; Ferrari R; Dagani F
Pharmacol Res; 1995 Jun; 31(6):361-9. PubMed ID: 8685074
[TBL] [Abstract][Full Text] [Related]
16. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y
Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275
[TBL] [Abstract][Full Text] [Related]
17. Alteration of pallidal cholinergic activity in MPTP-treated monkeys: effect of dihydro-alpha-ergocryptine (DEK).
Curti D; Izzo E; Benzi G
Neurosci Lett; 1994 Feb; 168(1-2):213-6. PubMed ID: 8028778
[TBL] [Abstract][Full Text] [Related]
18. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
[TBL] [Abstract][Full Text] [Related]
19. Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model.
Brownell AL; Canales K; Chen YI; Jenkins BG; Owen C; Livni E; Yu M; Cicchetti F; Sanchez-Pernaute R; Isacson O
Neuroimage; 2003 Oct; 20(2):1064-75. PubMed ID: 14568476
[TBL] [Abstract][Full Text] [Related]
20. 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.
Doudet DJ; Chan GL; Holden JE; McGeer EG; Aigner TA; Wyatt RJ; Ruth TJ
Synapse; 1998 Jul; 29(3):225-32. PubMed ID: 9635892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
